open access

Vol 7, No 5 (2018)
REVIEW ARTICLES
Published online: 2018-11-27
Get Citation

Monitoring of glucose metabolism in patients receiving enteral nutrition

Urszula Dworzecka, Ewa Otto-Buczkowska
DOI: 10.5603/DK.2018.0023
·
Clinical Diabetology 2018;7(5):230-233.

open access

Vol 7, No 5 (2018)
REVIEW ARTICLES
Published online: 2018-11-27

Abstract

Hyperglycemia is frequently occurring in critically ill patients and the incidence is particularly high in patients receiving nutrition support. One of the forms of such nutrition is enteral nutrition, which is used particularly often. There are patients with type 1 diabetes, type 2 diabetes and other forms of diabetes as well as patients who have not previously been diagnosed with diabetes in this group of patients. The basis of pharmacotherapy in this case is an insulin therapy. The principles of such a therapy in patients with previously diagnosed diabetes are regulated by PTD guidelines. According to literature data, hyperglycemic patients with no previously diagnosed diabetes require special attention. The pathomechanism of these disorders is very complex and these patients require special care in determining the insulin therapy program. So far, there are no unambiguous guidelines in this area.

Abstract

Hyperglycemia is frequently occurring in critically ill patients and the incidence is particularly high in patients receiving nutrition support. One of the forms of such nutrition is enteral nutrition, which is used particularly often. There are patients with type 1 diabetes, type 2 diabetes and other forms of diabetes as well as patients who have not previously been diagnosed with diabetes in this group of patients. The basis of pharmacotherapy in this case is an insulin therapy. The principles of such a therapy in patients with previously diagnosed diabetes are regulated by PTD guidelines. According to literature data, hyperglycemic patients with no previously diagnosed diabetes require special attention. The pathomechanism of these disorders is very complex and these patients require special care in determining the insulin therapy program. So far, there are no unambiguous guidelines in this area.
Get Citation

Keywords

enteral nutrition; hyperglycemia; diabetes; non-diabetic hyperglycemia; glycemic control; insulin therapy

About this article
Title

Monitoring of glucose metabolism in patients receiving enteral nutrition

Journal

Clinical Diabetology

Issue

Vol 7, No 5 (2018)

Pages

230-233

Published online

2018-11-27

DOI

10.5603/DK.2018.0023

Bibliographic record

Clinical Diabetology 2018;7(5):230-233.

Keywords

enteral nutrition
hyperglycemia
diabetes
non-diabetic hyperglycemia
glycemic control
insulin therapy

Authors

Urszula Dworzecka
Ewa Otto-Buczkowska

References (34)
  1. Hudson L, Chittams J, Griffith C, et al. Malnutrition Identified by Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition Is Associated With More 30-Day Readmissions, Greater Hospital Mortality, and Longer Hospital Stays: A Retrospective Analysis of Nutrition Assessment Data in a Major Medical Center. JPEN J Parenter Enteral Nutr. 2018; 42(5): 892–897.
  2. Taylor BE, McClave SA, Martindale RG, et al. Society of Critical Care Medicine, American Society of Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. 2016; 44(2): 390–438.
  3. Goéré D, Cunha ASa. Parenteral and enteral nutritional support (excluding immunonutrition). J Visc Surg. 2015; 152 Suppl 1: S8–SS13.
  4. Klek S, Szybinski P, Szczepanek K. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg. 2014; 38(4): 803–812.
  5. Garth AK, Newsome CM, Simmance N, et al. Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet. 2010; 23(4): 393–401.
  6. Elia M. Oral nutritional support in patients with cancer of the gastrointestinal tract. Journal of Human Nutrition and Dietetics. 2011; 24(5): 417–420.
  7. Mulasi U, Vock DM, Kuchnia AJ, et al. Malnutrition Identified by the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition Consensus Criteria and Other Bedside Tools Is Highly Prevalent in a Sample of Individuals Undergoing Treatment for Head and Neck Cancer. JPEN J Parenter Enteral Nutr. 2016 [Epub ahead of print]; 42(1): 139–147.
  8. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1): 11–48.
  9. Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013; 13(1): 155–162.
  10. Deane AM, Rayner CK, Keeshan A, et al. The effects of critical illness on intestinal glucose sensing, transporters, and absorption. Crit Care Med. 2014; 42(1): 57–65.
  11. Davidson P, Kwiatkowski CA, Wien M. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient. Nutr Clin Pract. 2015; 30(5): 652–659.
  12. Valizadeh Hasanloei MA, Shariatpanahi ZV, Vahabzadeh D, et al. Non-diabetic Hyperglycemia and Some of Its Correlates in ICU Hospitalized Patients Receiving Enteral Nutrition. Maedica (Buchar). 2017; 12(3): 174–179.
  13. American Diabetes Association. 14. Diabetes Care in the Hospital. Diabetes Care. 2017; 40(Suppl 1): S120–S127.
  14. McMahon MM, Nystrom E, Braunschweig C, et al. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, American Society for Parenteral and Enteral Nutrition. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013; 37(1): 23–36.
  15. Diabetology C. 2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clinical Diabetology. 2018; 7(1): 1–90.
  16. Acerini C, Craig ME, de Beaufort C, et al. Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Pediatr Diabetes. 2014; 15 Suppl 20: 1–3.
  17. Introduction:Standards of Medical Care in Diabetes—2018. Diabetes Care. 2017; 41(Supplement 1): S1–S2.
  18. Aloi J, Bode BW, Ullal J, et al. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. J Diabetes Sci Technol. 2017; 11(1): 12–16.
  19. Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013; 17(4): R159.
  20. Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009; 32(4): 594–596.
  21. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists, American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009; 32(6): 1119–1131.
  22. Smiley D, Umpierrez G. Management of hyperglycemia in hospitalized patients. Annals of the New York Academy of Sciences. 2010; 1212(1): 1–11.
  23. Buczkowska EO, Sayeed MM, Maitra SR, et al. Increased insulin responsiveness in endotoxicosis. Circ Shock. 1979; 6(1): 1–6.
  24. Vennard KC, Selen DJ, Gilbert MP. THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY-ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION. Endocr Pract. 2018 [Epub ahead of print].
  25. McCulloch A, Bansiya V, Woodward JM. Addition of Insulin to Parenteral Nutrition for Control of Hyperglycemia. JPEN J Parenter Enteral Nutr. 2018; 42(5): 846–854.
  26. Vallumsetla N, Epp L, Hurt RT, et al. Effect of Home Enteral Nutrition on Diabetes and Its Management. Nutr Clin Pract. 2018 [Epub ahead of print].
  27. Fatati G, Di Donato A, Grandone I, et al. Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study. Adv Ther. 2018; 35(6): 809–816.
  28. Ramos A, Zapata L, Vera P, et al. Transition from intravenous insulin to subcutaneous long-acting insulin in critical care patients on enteral or parenteral nutrition. Endocrinol Diabetes Nutr. 2017; 64(10): 552–556.
  29. Hijaze D, Szalat A. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards. Nutr Clin Pract. 2017; 32(4): 557–562.
  30. Verçoza Viana M, Verçoza Viana L, Tavares AL, et al. Insulin Regimens to Treat Hyperglycemia in Hospitalized Patients on Nutritional Support: Systematic Review and Meta-Analyses. Ann Nutr Metab. 2017; 71(3-4): 183–194.
  31. Kapała A. Dieta w chorobie nowotworowej. Buchmann, Warszawa 2018.
  32. Kumpf VJ, de Aguilar-Nascimento JE, Diaz-Pizarro Graf JI, et al. FELANPE, American Society for Parenteral and Enteral Nutrition. ASPEN–FELANPE Clinical Guidelines. JPEN J Parenter Enteral Nutr. 2017; 41(1): 104–112.
  33. Patkova A, Joskova V, Havel E, et al. Energy, Protein, Carbohydrate, and Lipid Intakes and Their Effects on Morbidity and Mortality in Critically Ill Adult Patients: A Systematic Review. Adv Nutr. 2017; 8(4): 624–634.
  34. Schetz M, Casaer MP, Van den Berghe G. Does artificial nutrition improve outcome of critical illness? Crit Care. 2013; 17(1): 302.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl